Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1986;9(1):56-62.
The paper presents the results of the study of medical impact of AUCPAHP. The study was performed in an organized population comprising 43197 males aged 40-54 years, including an intervention group of 23378 subjects and a control group of 19819. The active, mainly secondary prevention of arterial hypertension in 12 collaborative centres during 3-5 years has caused a decrease in overall mortality in the intervention group by 17.3% compared with that in the control group, in stroke mortality by 52.4% and non-fatal MI morbidity by 23.9%. CHD mortality has turned out to be practically equal in the two groups.
本文介绍了[AUCPAHP(此处可能有误,不太明确准确含义)]的医学影响研究结果。该研究在一个有组织的人群中进行,包括43197名年龄在40 - 54岁的男性,其中干预组有23378名受试者,对照组有19819名。在12个协作中心进行了3 - 5年的以动脉高血压为主的积极二级预防,使干预组的总死亡率相比对照组降低了17.3%,中风死亡率降低了52.4%,非致命性心肌梗死发病率降低了23.9%。结果显示,两组的冠心病死亡率实际上相当。